IOVS Journal of Clinical Microbiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kubo, M.
Right arrow Articles by Usui, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kubo, M.
Right arrow Articles by Usui, M.
(Investigative Ophthalmology and Visual Science. 2001;42:1539-1546.)
© 2001 by The Association for Research in Vision and Ophthalmology, Inc.

Immunogenicity of Human Amniotic Membrane in Experimental Xenotransplantation

Masato Kubo, Yasushi Sonoda, Ryuji Muramatsu and Masahiko Usui

From the Department of Ophthalmology, Tokyo Medical University, Tokyo, Japan.

PURPOSE. The immunogenic characterization of amniotic membrane is still unknown. This study was designed to examine the immunogenicity of human amniotic membrane, by using experimental xenotransplantation models.

METHODS. Anti-human class I, class II, and Fas ligand monoclonal antibodies were used against cryopreserved amniotic membrane and cell viability tested for cryopreserved amniotic membrane. Amniotic membranes were then transplanted to the limbal area, intracorneal space, and under the kidney capsule. The scores of transparency and neovascularization after transplantation were recorded by slit lamp microscopy. Host cell infiltration was examined by hematoxylin-eosin or immunohistochemical staining. Control grafts were transplanted human cryopreserved skin grafts.

RESULTS. Strong class I expression was observed in amniotic epithelium, mesenchymal cells, and fibroblasts in cryopreserved amniotic membrane. Some fibroblast cells unexpectedly expressed class II antigen. Fas ligand–positive cells were also detected in mesenchymal cells of amniotic stroma. Approximately 50% of epithelial cells of amniotic membrane cryopreserved for several months were still viable. In limbal transplantation, although some CD4+ and CD8+ T cells surrounded the amniotic graft, the response was mild. In intracorneal transplantation, all grafted amniotic membranes were accepted and clear, without host cell infiltration. In contrast, all skin grafts were rejected within 3 weeks after intracorneal transplantation. In amniotic membrane transplantation under the kidney capsule, extremely few host vessels and cells infiltrated the amniotic membrane; however, more host cells infiltrated the skin tissues under the kidney capsule.

CONCLUSIONS. Amniotic membrane seems to be immune-privileged tissue and to contain some immunoregulatory factors, including HLA-G and Fas ligand. The amniotic membrane may be useful to supplement corneal collagen, and it may be applied not only to the ocular surface but also intracorneally.




This article has been cited by other articles:


Home page
 Stem CellsHome page
O. Parolini, F. Alviano, G. P. Bagnara, G. Bilic, H.-J. Buhring, M. Evangelista, S. Hennerbichler, B. Liu, M. Magatti, N. Mao, et al.
Concise Review: Isolation and Characterization of Cells from Human Term Placenta: Outcome of the First International Workshop on Placenta Derived Stem Cells
Stem Cells, February 1, 2008; 26(2): 300 - 311.
[Abstract] [Full Text] [PDF]

Home page
 Br. J. Ophthalmol.Home page
M Nubile, H S Dua, T E.-M Lanzini, P Carpineto, M Ciancaglini, L Toto, and L Mastropasqua
Amniotic membrane transplantation for the management of corneal epithelial defects: an in vivo confocal microscopic study
Br. J. Ophthalmol., January 1, 2008; 92(1): 54 - 60.
[Abstract] [Full Text] [PDF]

Home page
 Biol. Reprod.Home page
S. Ilancheran, A. Michalska, G. Peh, E. M Wallace, M. Pera, and U. Manuelpillai
Stem Cells Derived from Human Fetal Membranes Display Multilineage Differentiation Potential
Biol Reprod, September 1, 2007; 77(3): 577 - 588.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
M. Wang, A. Yoshida, H. Kawashima, M. Ishizaki, H. Takahashi, and J. Hori
Immunogenicity and antigenicity of allogeneic amniotic epithelial transplants grafted to the cornea, conjunctiva, and anterior chamber.
Invest. Ophthalmol. Vis. Sci., April 1, 2006; 47(4): 1522 - 1532.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
T. Nakamura, M. Yoshitani, H. Rigby, N. J. Fullwood, W. Ito, T. Inatomi, C. Sotozono, T. Nakamura, Y. Shimizu, and S. Kinoshita
Sterilized, Freeze-Dried Amniotic Membrane: A Useful Substrate for Ocular Surface Reconstruction
Invest. Ophthalmol. Vis. Sci., January 1, 2004; 45(1): 93 - 99.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
S.-E. Ti, D. Anderson, A. Touhami, C. Kim, and S. C. G. Tseng
Factors Affecting Outcome Following Transplantation of Ex vivo Expanded Limbal Epithelium on Amniotic Membrane for Total Limbal Deficiency in Rabbits
Invest. Ophthalmol. Vis. Sci., August 1, 2002; 43(8): 2584 - 2592.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by the Association for Research in Vision and Ophthalmology